Hyperthermia Plus Chemotherapy May Be Effective in Pancreatic Cancer

Newsfeed Image, Light Gray Text On Dark Gray Background
Patients with advanced pancreatic cancer and ascites may benefit from regional radiofrequency thermotherapy (RFTT) in conjunction with systemic and intraperitoneal (IP) chemotherapy, according to a study published in the Journal of Global Oncology.

Evidence from prior studies suggests that direct delivery of cytotoxic drugs to the tumor-harboring compartment may be more effective in increasing tumor response rates compared with systemic administration, and it has been demonstrated that hyperthermia can change the characteristics of cancer cells, making them more susceptible to treatment. Read more . . .